United Kingdom Interventional Cardiology Market Databook with Annualized Market Revenues (USD), Volume (units) and Average Prices (USD) Data for Each of the Market Segments
December 23, 2020 02:43 ET
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "United Kingdom Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires, Coronary Stents and Others" report has been...
Global Percutaneous Coronary Intervention Market Analysis - 2018-2027
November 09, 2020 07:58 ET
|
Research and Markets
Dublin, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The "Global Percutaneous Coronary Intervention Market Outlook 2027" report has been added to ResearchAndMarkets.com's offering. The global percutaneous...
Global Coronary Stent Market to Witness a CAGR of 8.7% during 2019-2025
May 08, 2019 07:53 ET
|
Energias Market Research
NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- The global coronary stent market is expected to grow from USD 7,756 million in 2018 to USD 13,907 million in 2025, at a CAGR of 8.7% from 2019 to 2025. The...
Amaranth Presented Interim Nine-Month Follow-up MAGNITUDE (98 micron) and Two-Year Follow-up APTITUDE (115 micron) Data at EuroPCR Symposium
May 23, 2018 08:30 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , May 23, 2018 (GLOBE NEWSWIRE) -- Amaranth Medical, a medical device company developing next-generation bioresorbable scaffolds for the interventional cardiology market, provided...
Amaranth Medical Showcases Breadth of BRS Pipeline at TCT, Unveiling 9-mo Interim Imaging Results from 98 micron MAGNITUDE and Update on 115-micron APTITUDE
October 25, 2017 13:21 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Oct. 25, 2017 (GLOBE NEWSWIRE) -- Amaranth Medical, a medical device company developing next-generation bioresorbable scaffolds for the interventional cardiology market, will...
Amaranth Medical Initiates Trial of Sub-100-Micron MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold
November 01, 2016 08:00 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Nov. 01, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced the initiation of a clinical study of the Company’s latest-generation...
Global and China Coronary Stent Market to Benefit from Rising Demand for Minimally Invasive Treatments: QYResearchReports.com
July 14, 2016 08:33 ET
|
QY Research Reports
Brooklyn, NY , July 14, 2016 (GLOBE NEWSWIRE) -- The aging population is increasingly accepting minimally invasive surgeries and treatments. Advances in medical devices and the rising government...
Amaranth Medical On Track to Complete Enrollment in RENASCENT-II Study of 120-Micron APTITUDE™ Sirolimus-Eluting Bioresorbable Scaffold in May
May 18, 2016 03:01 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , May 18, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, provided a clinical update on its ongoing RENASCENT-II study of its novel APTITUDE™...